Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaxart Inc (NQ: VXRT ) 0.6901 -0.0077 (-1.10%) Streaming Delayed Price Updated: 2:39 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vaxart Inc < Previous 1 2 3 4 5 6 7 8 Next > Is Vaxart a Buy? May 12, 2021 Can this troubled coronavirus vaccine developer redeem itself and its investors? Via The Motley Fool Exposures COVID-19 Vaxart’s No-Shot Vaccine Is a Potential Game Changer May 11, 2021 VXRT stock is down from its highs, but there's no need to worry, as Vaxart has a unique Covid-19 vaccine and some encouraging clinical data. Via InvestorPlace Exposures COVID-19 Is Vaccine Maker Vaxart Worth Holding From Here? May 09, 2021 As with most investment decisions, whether to hold depends on the situation. Here are some things to think about. Via The Motley Fool Exposures COVID-19 Better Vaccine Stock: Ocugen or Vaxart? May 07, 2021 Here's how the biotechs compare on several key fronts. Via The Motley Fool Exposures COVID-19 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 06, 2021 Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares... Via Benzinga 58 Stocks Moving In Thursday's Mid-Day Session May 06, 2021 Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares surged 92.9% to $2.3150. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology... Via Benzinga 30 Stocks Moving in Thursday's Pre-Market Session May 06, 2021 Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutics showcased data for Elamipretide in dry age-related... Via Benzinga Vaxart's Vaccine Candidate Is a Pill, Not a Shot. Does It Matter? May 06, 2021 If it can reach the market of people that are hesitant to be vaccinated, yes. Via The Motley Fool Exposures COVID-19 Vaxart Has 3 Advantages Over Pfizer and Moderna May 06, 2021 Its coronavirus vaccine candidate may stand out, if upcoming trials are successful. Via The Motley Fool Exposures COVID-19 70 Biggest Movers From Yesterday May 06, 2021 Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters... Via Benzinga 64 Biggest Movers From Yesterday May 05, 2021 Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... Via Benzinga Exposures COVID-19 Why Vaxart Stock Is Surging Today May 04, 2021 Investors are excited about the company's experimental COVID-19 vaccine. Via The Motley Fool Exposures COVID-19 44 Stocks Moving In Tuesday's Mid-Day Session May 04, 2021 Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target... Via Benzinga Exposures COVID-19 Why Vaxart Shares Popped 78% in April May 04, 2021 Shareholders keep getting their hopes up for the company's tablet-based COVID-19 vaccine. Via The Motley Fool Exposures COVID-19 Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants May 04, 2021 Vaxart Inc has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1. Via Talk Markets Exposures COVID-19 The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data May 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 04, 2021 Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7... Via Benzinga Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants May 04, 2021 Vaxart Inc (NASDAQ: VXRT) has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1. Data obtained... Via Benzinga Exposures COVID-19 26 Stocks Moving in Tuesday's Pre-Market Session May 04, 2021 Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares rose 60.5% to $1.99 in pre-market trading. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... Via Benzinga Exposures COVID-19 52 Biggest Movers From Yesterday May 04, 2021 Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session May 03, 2021 Gainers Precipio (NASDAQ: Via Benzinga Vaxart Slides After Reporting Delay Of Trial For Potential COVID-19 Oral Vaccine May 03, 2021 Shares of Vaxart are under pressure on Monday after the company reported worse-than-expected first quarter losses and said that its Phase II trial of VXA-CoV2-1 is now expected to start mid-year 2021... Via Talk Markets Exposures COVID-19 Mid-Afternoon Market Update: Crude Oil Rises 1.5%; AVROBIO Shares Plummet May 03, 2021 Toward the end of trading Monday, the Dow traded up 0.82% to 34,152.49 while the NASDAQ fell 0.36% to 13,912.07. The S&P also rose, gaining 0.41% to 4,198.29. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To Watch May 03, 2021 Shares of Ocugen Inc. and Vaxart Inc. are moving Monday, May 3. Ocugen shares gapped higher after the company's studies showed that COVAXIN is potentially effective against three key variants of... Via Talk Markets Vaxart Stock Plummets On Growing Losses As Investors Eye Covid Pill May 03, 2021 Vaxart stock plummeted Monday ahead of a key presentation for its oral Covid vaccine and after the company reported growing first-quarter losses. Via Investor's Business Daily Exposures COVID-19 12 Health Care Stocks Moving In Monday's Intraday Session May 03, 2021 Gainers Precipio (NASDAQ:PRPO) stock moved upwards by 111.42% to $3.85 during Monday's regular session. The current volume of 113.0 million shares is 18552.84% of... Via Benzinga 2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To Watch May 03, 2021 Ocugen Inc. (NASDAQ: OCGN) and Vaxart Inc. (NASDAQ: VXRT) are moving Monday. Ocugen shares gapped higher after the company's studies showed that COVAXIN is potentially... Via Benzinga Mid-Day Market Update: Nasdaq Drops 50 Points; Ocugen Shares Spike Higher May 03, 2021 Midway through trading Monday, the Dow traded up 0.92% to 34,187.80 while the NASDAQ fell 0.37% to 13,910.67. The S&P also rose, gaining 0.36% to 4,196.13. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 32 Stocks Moving In Monday's Mid-Day Session May 03, 2021 Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 99.7% to $14.42 after jumping 38% on Friday. Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 30.5% to $64.... Via Benzinga Mid-Morning Market Update: Markets Open Higher; Estée Lauder Reports Mixed Q3 Results May 03, 2021 Following the market opening Monday, the Dow traded up 0.80% to 34,147.27 while the NASDAQ rose 0.54% to 14,038.00. The S&P also rose, gaining 0.65% to 4,208.31. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
